Uncategorized
Valeant Pharmaceuticals CEO returns after medical leave of absence
Valeant Pharmaceuticals International announced in a press release that J. Michael Pearson has returned as its CEO after taking medical leave of absence for severe pneumonia and other complications.Howard B. Schiller, who had been named Valeant’s interim CEO, will continue as a member of Valeant’s board of directors while transitioning out of his current duties, according to the release. Robert A. Ingram has been named chairman of the board, with Valeant separating the roles of chairman and CEO, the release reported.